The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors

Nature Immunology

Volumn 12, Issue 8, 2011, Pages 742-751

  Yuk, Jae Min ^a   Shin, Dong Min ^a   Lee, Hye Mi ^a   Kim, Jwa Jin ^a   Kim, Sun Woong ^a   Jin, Hyo Sun ^a   Yang, Chul Su ^a,f   Park, Kyeong Ah ^a   Chanda, Dipanjan ^b   Kim, Don Kyu ^b   Huang, Song Mei ^a   Lee, Sang Ki ^a   Lee, Chul Ho ^c   Kim, Jin Man ^a   Song, Chang Hwa ^a   Lee, Soo Young ^d   Hur, Gang Min ^a   Moore, David D ^e   Choi, Hueng Sik ^b   Jo, Eun Kyeong ^a  

^a Chungnam National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Ewha Womans University   (South Korea)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ORPHAN NUCLEAR RECEPTOR; REGULATOR PROTEIN; SMALL HETERODIMER PARTNER PROTEIN; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW TRANSPLANTATION; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; FEMALE; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEPSIS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTORS; UBIQUITINATION;

EID: 80052020185     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2064     Document Type: Review

References (49)

1. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891 (2002). (Pubitemid 36019643)
2. Nathan, C. Points of control in inflammation. Nature 420, 846-852 (2002). (Pubitemid 36019637)
3. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680 (2001). (Pubitemid 32747155)
4. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.-A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005). (Pubitemid 40835033)
5. Wang, J., Hu, Y., Deng, W.W. & Sun, B. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect. 11, 321-327 (2009).
6. Seol, W., Choi, H.S. & Moore, D.D. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272, 1336-1339 (1996). (Pubitemid 26199974)
7. Lee, Y.S., Chanda, D., Sim, J., Park, Y.Y. & Choi, H.S. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int. Rev. Cytol. 261, 117-158 (2007). (Pubitemid 46856618)
8. Bavner, A., Sanyal, S., Gustafsson, J.A. & Treuter, E. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol. Metab. 16, 478-488 (2005). (Pubitemid 41660864)
9. Chanda, D., Park, J.H. & Choi, H.S. Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocr. J. 55, 253-268 (2008). (Pubitemid 351670949)
10. Zhang, Y. et al. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48, 289-298 (2008). (Pubitemid 351975553)
11. Chen, Z.J. Ubiquitin signalling in the NF-kB pathway. Nat. Cell Biol. 7, 758-765 (2005).
12. Imperatore, F. et al. Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med. 30, 1175-1181 (2004). (Pubitemid 38833373)
13. Yoshitomi, H. et al. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949-960 (2005). (Pubitemid 40524464)
14. Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591 (2009).
15. Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103, 8459-8464 (2006). (Pubitemid 43838477)
16. Dong, C., Davis, R.J. & Flavell, R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72 (2002). (Pubitemid 34293420)
17. Hacker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
18. Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor ?B signaling. Immunol. Rev. 210, 171-186 (2006).
19. Kawai, T. & Akira, S. Signaling to NF-kB by Toll-like receptors. Trends Mol. Med. 13, 460-469 (2007).
20. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006). (Pubitemid 43261452)
21. Janeway, C.A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002). (Pubitemid 34293424)
22. Sun, S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8, 501-511 (2008).
23. Deng, L. et al. Activation of the I?B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
24. Fogarty, S. et al. Calmodulin-dependent protein kinase kinase-β activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem. J. 426, 109-118 (2010).
25. Hardie, D.G. New roles for the LKB1?AMPK pathway. Curr. Opin. Cell Biol. 17, 167-173 (2005).
26. Chanda, D. et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J. Biol. Chem. 284, 28510-28521 (2009).
27. Kim, Y.D. et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57, 306-314 (2008).
28. Liu, Q.P., Fruit, K., Ward, J. & Correll, P.H. Negative regulation of macrophage activation in response to IFN-γ and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163, 6606-6613 (1999).
29. Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517-526 (2000).
30. Lam, I.P., Lee, L.T., Choi, H.S., Alpini, G. & Chow, B.K. Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP). Am. J. Physiol. Gastrointest. Liver Physiol. 297, G90-G97 (2009).
31. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124-1136 (2007). (Pubitemid 350235020)
32. Zhang, Y. et al. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol. Cell. Biol. 30, 1341-1356 (2010).
33. Wang, Y. et al. Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7, 139-147 (2006). (Pubitemid 43135879)
34. Miao, J. et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev. 23, 986-996 (2009).
35. Viollet, B. et al. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 33, 395-402 (2007). (Pubitemid 350218220)
36. Sag, D., Carling, D., Stout, R.D. & Suttles, J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633-8641 (2008).
37. Zhao, X. et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L497-L504 (2008).
38. Jhun, B.S. et al. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 318, 372-380 (2004). (Pubitemid 38553790)
39. Han, S., Stuart, L.A. & Degen, S.-J. Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30, 9768-9780 (1991).
40. Bezerra, J.A., Witte, D.P., Aronow, B.J. & Degen, S.J. Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 18, 394-399 (1993). (Pubitemid 23225112)
41. Wang, M.H., Skeel, A. & Leonard, E.J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97, 720-727 (1996). (Pubitemid 26057091)
42. Chen, Y.Q., Fisher, J.H. & Wang, M.H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 161, 4950-4959 (1998). (Pubitemid 28492076)
43. Ray, M. et al. Inhibition of TLR4-Induced I?B kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J. Immunol. 185, 7309-7316 (2010).
44. Reichardt, H.M. et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173 (2001). (Pubitemid 34062308)
45. De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-?B or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522 (2003). (Pubitemid 37059110)
46. Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005). (Pubitemid 41242636)
47. Wang, L. et al. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721-731 (2002). (Pubitemid 34650069)
48. Yang, C.S. et al. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J. Exp. Med. 204, 583-594 (2007).
49. Schingnitz, U. et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184, 5271-5279 (2010).